Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population
about
The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanismsGlutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities.Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women.Emotional support predicts more sickness absence and poorer self assessed work ability: a two-year prospective cohort study.Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study.Overexpression of MMP-9 and its inhibitors in blood mononuclear cells after myocardial infarction--is it associated with depressive symptomatology?Provitamin A carotenoids are independently associated with matrix metalloproteinase-9 in plasma samples from a general population.Correlation of circulating MMP-9 with white blood cell count in humans: effect of smoking.The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trialAre Hill's criteria for causality satisfied for vitamin D and periodontal disease?Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapComparison of whole blood RNA preservation tubes and novel generation RNA extraction kits for analysis of mRNA and MiRNA profiles.Plasma Matrix Metalloproteinase-9 Levels Predict First-Time Coronary Heart Disease: An 8-Year Follow-Up of a Community-Based Middle Aged Population.Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis.Hepatocyte growth factor in patients with coronary artery disease and its relation to periodontal condition.Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.Effect of Smoking on Metalloproteinases (MMPs) Activity in Patients with Acute Myocardial Infarction (AMI).TURN Score Predicts 24-Hour Cerebral Edema After IV Thrombolysis.Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans.Fibrosis as measured by the biomarker, tissue inhibitor metalloproteinase-1, predicts mortality in Age Gene Environment Susceptibility-Reykjavik (AGES-Reykjavik) Study.A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients.Extracellular matrix proteins matrix metallopeptidase 9 (MMP9) and soluble intercellular adhesion molecule 1 (sICAM-1) and correlations with clinical staging in euthymic bipolar disorder.Serum MMP-9 Diagnostics, Prognostics, and Activation in Acute Coronary Syndrome and Its Recurrence.Effects of Simvastatin on Proinflammatory Cytokines and Matrix Metalloproteinases in Hypercholesterolemic Individuals
P2860
Q27021538-876D83AA-BD25-4059-BE9C-B833486F642CQ33421711-B9F9487E-341D-4EC3-A761-08D9C0B0BCB1Q33658683-670DF9BA-1A4A-4626-B4AC-67C15B1F7704Q33729208-734BF483-7B74-4EBE-A301-60F116B42961Q33809526-22F34E2A-315A-4CEA-ABB5-36FBF1774AD6Q34083836-07C9DE48-F2DE-46F6-B3E6-617808636E9EQ34637321-9D36BB4D-848E-48A0-86AB-A3E3E4875E67Q34794044-91731A97-90EF-4D52-94DA-CB1EC3337EC4Q34795882-85181F8A-7546-4FDB-9D1E-F20618F24FB2Q34891053-30AC9C2B-BA49-4BD4-95E3-20A58EEABAF4Q35178857-1075AAF1-2EEA-45BB-BF74-0DDA527CD6BBQ35484367-4B4434ED-7A43-4192-B179-14972564A04CQ35781795-CDE0A1D5-A3AC-45D9-AF16-3928DCC3040EQ36246052-8B64736C-AA93-4D3A-9635-715B16CF420EQ37390401-9407C965-0832-4F3F-BD58-8CAC2B6A9DC6Q37484777-B52DAD32-A42B-4717-98D5-8355CF2E2573Q38587974-6A9B016D-BF74-4AC0-8052-39C72D4FCE67Q40572133-0CC46311-935F-49DD-AD1D-CBAFB109DAE3Q44270574-FC99D3FB-35CB-4C40-9D26-3811084C9F92Q47613602-8382E7DF-B977-4B76-A0EF-5E302B267D26Q47975464-334608DB-6574-4679-943B-9141EDB5BBDFQ48060018-E1C325D7-2A08-41C4-9CD9-18F3F3C2B2A8Q48212487-750EB825-77C1-49EB-BAC9-C7EA3BF10A3FQ57607566-4B339ADD-EE29-40C9-B9FF-EA35CD086836
P2860
Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Circulating matrix metalloprot ...... middle-aged normal population
@ast
Circulating matrix metalloprot ...... middle-aged normal population
@en
Circulating matrix metalloprot ...... middle-aged normal population.
@nl
type
label
Circulating matrix metalloprot ...... middle-aged normal population
@ast
Circulating matrix metalloprot ...... middle-aged normal population
@en
Circulating matrix metalloprot ...... middle-aged normal population.
@nl
prefLabel
Circulating matrix metalloprot ...... middle-aged normal population
@ast
Circulating matrix metalloprot ...... middle-aged normal population
@en
Circulating matrix metalloprot ...... middle-aged normal population.
@nl
P2093
P2860
P1433
P1476
Circulating matrix metalloprot ...... middle-aged normal population
@en
P2093
Lena Jonasson
Lennart Nilsson
Margareta Kristenson
P2860
P356
10.1371/JOURNAL.PONE.0001774
P407
P577
2008-03-12T00:00:00Z